$ELTP Recent News Former CEO of Elite Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ELTP Recent News

Former CEO of Elite Pharmaceuticals sells all shares 10:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 4:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 5:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 12:07 p.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 1:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 2:27 p.m. Aug. 8, 2003 - Chris Kraeuter

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 9:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 9:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 11:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 1:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 12:01 a.m. May 10, 2013 - InvestorPlace.com
Racket of Their Own 12:01 a.m. Aug. 15, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 12:01 a.m. Sept. 4, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 6:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 1:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition

Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally 7:47 a.m. March 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 8:31 a.m. March 5, 2014 - GlobeNewswire
BlackBerry May Power Ford's Future Generation Cars 5:48 a.m. Feb. 25, 2014 - ACCESSWIRE
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201 8:01 a.m. Feb. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014 10:50 a.m. Feb. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014 4:27 p.m. Feb. 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
TrendingWallStreet.com Releases Updates on RFMD, EZPW, GFOX, and ELTP 1:17 a.m. Jan. 30, 2014 - ACCESSWIRE
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product 2:22 p.m. Jan. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 1:50 p.m. Dec. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note 8:00 a.m. Nov. 26, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 5:23 p.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013 8:45 a.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Bridge Loan Facility 7:45 a.m. Oct. 16, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products 7:45 a.m. Oct. 8, 2013 - GlobeNewswire
BlackBerry May be Going Private on Potential Fairfax Deal 9:27 a.m. Sept. 24, 2013 - ACCESSWIRE
Shutterstock Zooms to a new 52-week High after Pricing Secondary Offering 7:29 a.m. Sept. 23, 2013 - ACCESSWIRE
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride 7:51 a.m. Sept. 18, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 9:47 a.m. Sept. 3, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

SMART Modular Technologies Advances with CXL Compliance Achievements

Updated Category News Views 246

SMART Modular Technologies Achieves CXL Compliance In a significant development for the tech industry, SMART Modular Technologies, a well-respected name in integrated memory solutions, has successfully earned recognition on the CXL (Compute Express Link) Consortium’s Integrators' List. This announcement signifies their commitment to delivering high-quality memory...

Continue Reading
Navigating Legal Challenges: KinderCare Learning Companies Case

Updated Category News Views 201

Understanding the Legal Landscape for KinderCare Learning Companies In the evolving world of corporate governance, it is crucial for investors to stay informed, particularly regarding legal developments that may affect their interests. KinderCare Learning Companies has recently found itself at the center of a securities class action lawsuit, bringing attention to...

Continue Reading
ASP Isotopes Secures Overwhelming Approval for Renergen Deal

Updated Category News Views 198

ASP Isotopes Sees Major Support for Renergen Acquisition At a pivotal shareholders meeting, ASP Isotopes Inc. (NASDAQ: ASPI), an advanced materials company, announced that Renergen Limited's shareholders overwhelmingly approved its acquisition. The vote, which took place during a recent meeting, revealed that 99.80% of the shareholders in favor of the scheme, showcasing...

Continue Reading
ORR Protection Expands Fire Safety Solutions with DSI Deal

Updated Category News Views 198

ORR Protection Strengthens Its Fire Safety Solutions In a significant move to enhance its fire protection services, ORR Protection Systems, Inc. has acquired Detection & Suppression International (DSI). This strategic acquisition expands ORR Protection's capabilities and reinforces its position as a leader in the fire safety industry. About the Acquisition Located in...

Continue Reading
Analysis of Pennsylvania Housing Market Trends as Winter Arrives

Updated Category News Views 176

Understanding the Pennsylvania Housing Market's December Trends The Pennsylvania housing market exhibited a noticeable cooling trend in December, reflecting seasonal changes and economic patterns. The median sales price for homes fell approximately 5%, recorded at $289,000 in December, a decline from the $305,000 reported in November. Price Trends Compared to Previous...

Continue Reading